These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 10353942)

  • 1. Interferon and giant cell tumors.
    Dickerman JD
    Pediatrics; 1999 Jun; 103(6 Pt 1):1282-3. PubMed ID: 10353942
    [No Abstract]   [Full Text] [Related]  

  • 2. Generalised giant-cell tumour of bone: successful treatment of pulmonary metastases with interferon alpha, a case report.
    Kaiser U; Neumann K; Havemann K
    J Cancer Res Clin Oncol; 1993; 119(5):301-3. PubMed ID: 8440744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiangiogenic therapy of a recurrent giant cell tumor of the mandible with interferon alfa-2a.
    Kaban LB; Mulliken JB; Ezekowitz RA; Ebb D; Smith PS; Folkman J
    Pediatrics; 1999 Jun; 103(6 Pt 1):1145-9. PubMed ID: 10353921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful antiangiogenic therapy of giant cell angioblastoma with interferon alfa 2b: report of 2 cases.
    Marler JJ; Rubin JB; Trede NS; Connors S; Grier H; Upton J; Mulliken JB; Folkman J
    Pediatrics; 2002 Feb; 109(2):E37. PubMed ID: 11826247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Raloxifene can reduce giant cell tumor recurrence: a new adjuvant therapy.
    Namazi H
    Ann Surg Oncol; 2008 Jun; 15(6):1783-4. PubMed ID: 18157574
    [No Abstract]   [Full Text] [Related]  

  • 6. Caution with regard to the efficacy of interferon alfa-2b in the treatment of giant hemangiomas.
    Léauté-Labrèze C; Taïeb A
    Arch Dermatol; 1998 Oct; 134(10):1297-8. PubMed ID: 9801696
    [No Abstract]   [Full Text] [Related]  

  • 7. Aggressive central giant cell lesion of the maxilla: surgical management and the use of adjuvant interferon alfa-2a.
    Baker SB; Parikh PM; Rhodes DN; Abu-Ghosh A; Shad AT
    Plast Reconstr Surg; 2008 Aug; 122(2):77e-79e. PubMed ID: 18626327
    [No Abstract]   [Full Text] [Related]  

  • 8. Interferon-alpha-2b in the management of patients with relapsed and/or refractory Hodgkin's disease.
    Maloisel F; Voillat L; Chenard MP; Boehn A; Lioure B; Oberling F
    Ann Oncol; 1997 Apr; 8(4):405-6. PubMed ID: 9209674
    [No Abstract]   [Full Text] [Related]  

  • 9. Interferon for melanoma: another application of immunopharmacology.
    Nauman C
    JAMA; 1998 Apr 22-29; 279(16):1263. PubMed ID: 9565004
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical application of calcitonin in giant cell tumor of the bones].
    Umeda T; Kuwahara T; Takada N
    Gan To Kagaku Ryoho; 1988 Feb; 15(2):365-7. PubMed ID: 3341794
    [No Abstract]   [Full Text] [Related]  

  • 11. [Interferon: IntronA, Roferon].
    Gaudy-Marqueste C; Grob JJ
    Ann Dermatol Venereol; 2007 Dec; 134(12):917-21. PubMed ID: 18166911
    [No Abstract]   [Full Text] [Related]  

  • 12. Mediastinal hemangioma: successful treatment by alpha-2a interferon and postchemotherapy resection.
    Kumar P; Judson I; Nicholson AG; Ladas G
    J Thorac Cardiovasc Surg; 2002 Aug; 124(2):404-6. PubMed ID: 12167806
    [No Abstract]   [Full Text] [Related]  

  • 13. Is there still a role for interferon-alpha for newly diagnosed chronic myeloid leukemia in chronic phase?
    Quintás-Cardama A; Verstovsek S
    Leuk Lymphoma; 2007 Mar; 48(3):445-6. PubMed ID: 17454579
    [No Abstract]   [Full Text] [Related]  

  • 14. [Chemotherapy of malignant bone tumors].
    Höffken K; Seeber S; Gallmeier WM; Bruntsch U; Hossfeld DK; Schmidt CG
    Chirurg; 1977 Apr; 48(4):274-9. PubMed ID: 324726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interferon alfa-2a tretinoin in patients with metastatic renal cell carcinoma: a pilot study.
    Paule B; Bonhomme-Faivre L; Rudant E; Ferrière F
    Am J Health Syst Pharm; 1997 Jan; 54(2):190-2. PubMed ID: 9117809
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of Cytembena in the treatment of malignant musculoskeletal tumours.
    Matĕjovský Z
    Neoplasma; 1971; 18(5):473-80. PubMed ID: 4330363
    [No Abstract]   [Full Text] [Related]  

  • 17. Partial regrowth of scalp hair in a patient treated with extracorporeal photochemotherapy and interferon alpha 2a.
    Wollina U
    J Eur Acad Dermatol Venereol; 1998 Nov; 11(3):261-2. PubMed ID: 9883441
    [No Abstract]   [Full Text] [Related]  

  • 18. Recurrent and refractory giant cell tumor of the jaw.
    Rovelo MO; Kim R; Mascarenhas L; Hammoudeh J; Urata MM
    J Craniofac Surg; 2009 Nov; 20(6):2245-8. PubMed ID: 19934683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone marrow necrosis masquerading as interferon toxicity in chronic myeloid leukemia.
    Chim CS; Ma SK; Lam CK
    Leuk Lymphoma; 1999 Apr; 33(3-4):385-8. PubMed ID: 10221520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of large doses of drug compounds on changes in the blood indices of patients with malignant neoplasms of the extremities].
    Korolev VI; Gumennyĭ VS
    Vrach Delo; 1972 May; 5():51-5. PubMed ID: 4337733
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.